Literature DB >> 17716864

PKB and the mitochondria: AKTing on apoptosis.

Arnaud Parcellier1, Lionel A Tintignac, Elena Zhuravleva, Brian A Hemmings.   

Abstract

Cellular homeostasis depends upon the strict regulation of responses to external stimuli, such as signalling cascades triggered by nutrients and growth factors, and upon cellular metabolism. One of the major molecules coordinating complex signalling pathways is protein kinase B (PKB), a serine/threonine kinase also known as Akt. The number of substrates known to be phosphorylated by PKB and its interacting partners, as well as our broad understanding of how PKB is implicated in responses to growth factors, metabolic pathways, proliferation, and cell death via apoptosis is constantly increasing. Activated by the insulin/growth factor-phosphatidylinositol 3-kinase (PI3K) cascade, PKB triggers events that promote cell survival and prevent apoptosis. It is also now widely accepted that mitochondria are not just suppliers of ATP, but that they participate in regulatory and signalling events, responding to multiple physiological inputs and genetic stresses, and regulate both cell proliferation and death. Thus, mitochondria are recognized as important players in apoptotic events and it is logical to predict some form of interplay with PKB. In this review, we will summarize mechanisms by which PKB mediates its anti-apoptotic activities in cells and survey recent developments in understanding mitochondrial dynamics and their role during apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716864     DOI: 10.1016/j.cellsig.2007.07.010

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  92 in total

1.  The α-isoform of class II phosphoinositide 3-kinase is necessary for the activation of ERK but not Akt/PKB.

Authors:  Z G Cui; N Y Hong; H K Kang; D H Lee; Y K Lee; D B Park
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

Review 2.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

Review 3.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 4.  PI3K signaling in glioma--animal models and therapeutic challenges.

Authors:  Christine K Cheng; Qi-Wen Fan; William A Weiss
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

5.  Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.

Authors:  Lei Duan; Ricardo E Perez; Michael Hansen; Steven Gitelis; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

6.  Serine/threonine kinase akt activation regulates the activity of retinal serine/threonine phosphatases, PHLPP and PHLPPL.

Authors:  Yogita Kanan; Hiroyuki Matsumoto; Hongman Song; Maxim Sokolov; Robert E Anderson; Raju V S Rajala
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

7.  Conditional drug screening shows that mitotic inhibitors induce AKT/PKB-insensitive apoptosis.

Authors:  Maria Berndtsson; Emma Hernlund; Maria C Shoshan; Stig Linder
Journal:  J Chem Biol       Date:  2009-03-31

8.  Heat shock protein 70-mediated sensitization of cells to apoptosis by Carboxyl-Terminal Modulator Protein.

Authors:  Longzhen Piao; Yuwen Li; Keum-Jin Yang; Kyeong Ah Park; Hee Sun Byun; Minho Won; Janghee Hong; Jeong-Lan Kim; Gi Ryang Kweon; Gang Min Hur; Jeong Ho Seok; Jae Youl Cho; Taehoon Chun; Daniel Hess; Ragna Sack; Sauveur-Michel Maira; Derek P Brazil; Brian A Hemmings; Jongsun Park
Journal:  BMC Cell Biol       Date:  2009-07-15       Impact factor: 4.241

9.  The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death.

Authors:  Takahiro Miyawaki; Dimitry Ofengeim; Kyung-Min Noh; Adrianna Latuszek-Barrantes; Brian A Hemmings; Antonia Follenzi; R Suzanne Zukin
Journal:  Nat Neurosci       Date:  2009-04-06       Impact factor: 24.884

10.  Inhibition of PI3K-Akt signaling blocks exercise-mediated enhancement of adult neurogenesis and synaptic plasticity in the dentate gyrus.

Authors:  Elodie Bruel-Jungerman; Alexandra Veyrac; Franck Dufour; Jennifer Horwood; Serge Laroche; Sabrina Davis
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.